[Close]
- This page was created by volunteers like you!
- Help us make it even better. To learn more about contributing to MEpedia, click here.
- Join the movement
- Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
- Congratulations!
- MEpedia has got over 30 million views as of August 2022!
Zofran
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
 | This article is a stub. |
Zofran or ondansetron (generic name, oral) is drug used to treat nausea and vomiting.[1] It is a 5-HT3 receptor antagonist.[2] Zofran is also sold under the brand names Zofran ODT and Zuplenz.[1]
Theory[edit | edit source]
Evidence[edit | edit source]
Clinicians[edit | edit source]
Risks and safety[edit | edit source]
Serious side effects may occur with zofran including:
- blurred vision or vision loss (lasting from a few minutes to several hours)
- Slowed heart rate
- Difficultty breathing
- Anxiety
- Agitation
- Shivering
- feeling like you might pass out
- Urinating less than usual or not urinating at all
Zofran may impair your thinking or reactions, which may make driving unsafe.[1]
Costs and availability[edit | edit source]
Notable studies[edit | edit source]
- 2009, Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists - preliminary results[2] (Abstract)
See also[edit | edit source]
Learn more[edit | edit source]
- Zofran - drugs.com
References[edit | edit source]
- ↑ Jump up to: 1.0 1.1 1.2 "Zofran Uses, Dosage & Side Effects". Drugs.com. Retrieved November 29, 2020.
- ↑ Jump up to: 2.0 2.1 Späth, M.; Färber, D., L.; Welzel, D. (January 1, 2000). "Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists - preliminary results". Scandinavian Journal of Rheumatology. 29 (113): 72–77. doi:10.1080/030097400750001851-1. ISSN 0300-9742.
